Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erythropoietic Protoporphyria (EPP)”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableStudy completedNCT05572125
What this trial is testing

Iron Therapy in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic ProtoporphyriaIron-deficiency
Bispebjerg Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT06910358
What this trial is testing

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
Disc Medicine, Inc 150
Not applicableStudy completedNCT01688895
What this trial is testing

Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact

Who this might be right for
Erythropoietic ProtoporphyriaEPPX-Linked Protoporphyria+5 more
Icahn School of Medicine at Mount Sinai 150
Large-scale testing (Phase 3)Looking for participantsNCT05005975
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Who this might be right for
EPPXLP
Tanabe Pharma America, Inc. 301
Large-scale testing (Phase 3)Study completedNCT04402489
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria

Who this might be right for
EPPXLP
Tanabe Pharma America, Inc. 184
Testing effectiveness (Phase 2)Study completedNCT06388642
What this trial is testing

Pharmacokinetics of Afamelanotide in EPP Patients

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Europe Limited 28
Not applicableStudy completedNCT00004831
What this trial is testing

Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
FDA Office of Orphan Products Development 20
Testing effectiveness (Phase 2)Study completedNCT05020184
What this trial is testing

Effect of Oral Cimetidine in the Protoporphyrias

Who this might be right for
Erythropoietic ProtoporphyriaX-linked Protoporphyria
Amy K. Dickey, M.D. 26
Large-scale testing (Phase 3)Study completedNCT04578496
What this trial is testing

A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 16
Testing effectiveness (Phase 2)Study completedNCT05308472
What this trial is testing

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

Who this might be right for
Erythropoietic Protoporphyria
Disc Medicine, Inc 75
Not applicableStudy completedNCT02979249
What this trial is testing

Oral Iron for Erythropoietic Protoporphyrias

Who this might be right for
Erythropoietic ProtoporphyriaEPPX-linked Protoporphyria+1 more
Icahn School of Medicine at Mount Sinai 16
Not applicableStudy completedNCT03682731
What this trial is testing

Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Bispebjerg Hospital 14
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06971900
What this trial is testing

GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria (EPP)
Portal Therapeutics, Inc. 14
Large-scale testing (Phase 3)Enrolling By InvitationNCT05883748
What this trial is testing

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Who this might be right for
Erythropoietic Protoporphyria
Disc Medicine, Inc 230
Large-scale testing (Phase 3)Study completedNCT00004940
What this trial is testing

Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Brigham and Women's Hospital 50
Not applicableUnknownNCT05780840
What this trial is testing

Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Bispebjerg Hospital 6
Not applicableUnknownNCT00206869
What this trial is testing

Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Bispebjerg Hospital
Testing effectiveness (Phase 2)Study completedNCT01097044
What this trial is testing

Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 77
Large-scale testing (Phase 3)Study completedNCT01422915
What this trial is testing

Sorbent Therapy of the Cutaneous Porphyrias

Who this might be right for
Erythropoietic Protoporphyria
Brigham and Women's Hospital 4
Not applicableLooking for participantsNCT01561157
What this trial is testing

Longitudinal Study of the Porphyrias

Who this might be right for
Acute PorphyriasCutaneous Porphyrias
Icahn School of Medicine at Mount Sinai 1,500
Load More Results